Cargando…

Prevention of Arteriovenous Shunt Occlusion Using Microbubble and Ultrasound Mediated Thromboprophylaxis

BACKGROUND: Palliative shunts in congenital heart disease patients are vulnerable to thrombotic occlusion. High mechanical index (MI) impulses from a modified diagnostic ultrasound (US) transducer during a systemic microbubble (MB) infusion have been used to dissolve intravascular thrombi without an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutty, Shelby, Wu, Juefei, Hammel, James M., Abraham, Joseph R., Venkataraman, Jeeva, Abdullah, Ibrahim, Danford, David A., Radio, Stanley J., Lof, John, Porter, Thomas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959668/
https://www.ncbi.nlm.nih.gov/pubmed/24518555
http://dx.doi.org/10.1161/JAHA.113.000689
_version_ 1782308074242965504
author Kutty, Shelby
Wu, Juefei
Hammel, James M.
Abraham, Joseph R.
Venkataraman, Jeeva
Abdullah, Ibrahim
Danford, David A.
Radio, Stanley J.
Lof, John
Porter, Thomas R.
author_facet Kutty, Shelby
Wu, Juefei
Hammel, James M.
Abraham, Joseph R.
Venkataraman, Jeeva
Abdullah, Ibrahim
Danford, David A.
Radio, Stanley J.
Lof, John
Porter, Thomas R.
author_sort Kutty, Shelby
collection PubMed
description BACKGROUND: Palliative shunts in congenital heart disease patients are vulnerable to thrombotic occlusion. High mechanical index (MI) impulses from a modified diagnostic ultrasound (US) transducer during a systemic microbubble (MB) infusion have been used to dissolve intravascular thrombi without anticoagulation, and we sought to determine whether this technique could be used prophylactically to reduce thrombus burden and prevent occlusion of surgically placed extracardiac shunts. METHODS AND RESULTS: Heparin‐bonded ePTFE tubular vascular shunts of 4 mm×2.5 cm (Propaten; W.L Gore) were surgically placed in 18 pigs: a right‐sided side‐to‐side arteriovenous (AV, carotid‐jugular) shunt, and a left‐sided arterio‐arterial (AA, carotid‐carotid) interposition shunt in each animal. After shunt implantation, animals were randomly assigned to one of 3 groups. Transcutaneous, weekly 30‐minute treatments (total of 4 treatments) of either guided high MI US+MB (Group 1; n=6) using a 3% MRX‐801 MB infusion, or US alone (Group 2; n=6) were given separately to each shunt. The third group of 6 pigs received no treatments. The shunts were explanted after 4 weeks and analyzed by histopathology to quantify luminal thrombus area (mm(2)) for the length of each shunt. No pigs received antiplatelet agents or anticoagulants during the treatment period. The median overall thrombus burden in the 3 groups for AV shunts was 5.10 mm(2) compared with 4.05 mm(2) in AA (P=0.199). Group 1 pigs had significantly less thrombus burden in the AV shunts (median 2.5 mm(2)) compared with Group 2 (median 5.6 mm(2)) and Group 3 (median 7.5 mm(2)) pigs (P=0.006). No difference in thrombus burden was seen between groups for AA shunts. CONCLUSION: Transcutaneous US with intravenous MB is capable of preventing thrombus accumulation in arteriovenous shunts without the need for antiplatelet agents, and may be a method of preventing progressive occlusion of palliative shunts.
format Online
Article
Text
id pubmed-3959668
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-39596682014-03-20 Prevention of Arteriovenous Shunt Occlusion Using Microbubble and Ultrasound Mediated Thromboprophylaxis Kutty, Shelby Wu, Juefei Hammel, James M. Abraham, Joseph R. Venkataraman, Jeeva Abdullah, Ibrahim Danford, David A. Radio, Stanley J. Lof, John Porter, Thomas R. J Am Heart Assoc Original Research BACKGROUND: Palliative shunts in congenital heart disease patients are vulnerable to thrombotic occlusion. High mechanical index (MI) impulses from a modified diagnostic ultrasound (US) transducer during a systemic microbubble (MB) infusion have been used to dissolve intravascular thrombi without anticoagulation, and we sought to determine whether this technique could be used prophylactically to reduce thrombus burden and prevent occlusion of surgically placed extracardiac shunts. METHODS AND RESULTS: Heparin‐bonded ePTFE tubular vascular shunts of 4 mm×2.5 cm (Propaten; W.L Gore) were surgically placed in 18 pigs: a right‐sided side‐to‐side arteriovenous (AV, carotid‐jugular) shunt, and a left‐sided arterio‐arterial (AA, carotid‐carotid) interposition shunt in each animal. After shunt implantation, animals were randomly assigned to one of 3 groups. Transcutaneous, weekly 30‐minute treatments (total of 4 treatments) of either guided high MI US+MB (Group 1; n=6) using a 3% MRX‐801 MB infusion, or US alone (Group 2; n=6) were given separately to each shunt. The third group of 6 pigs received no treatments. The shunts were explanted after 4 weeks and analyzed by histopathology to quantify luminal thrombus area (mm(2)) for the length of each shunt. No pigs received antiplatelet agents or anticoagulants during the treatment period. The median overall thrombus burden in the 3 groups for AV shunts was 5.10 mm(2) compared with 4.05 mm(2) in AA (P=0.199). Group 1 pigs had significantly less thrombus burden in the AV shunts (median 2.5 mm(2)) compared with Group 2 (median 5.6 mm(2)) and Group 3 (median 7.5 mm(2)) pigs (P=0.006). No difference in thrombus burden was seen between groups for AA shunts. CONCLUSION: Transcutaneous US with intravenous MB is capable of preventing thrombus accumulation in arteriovenous shunts without the need for antiplatelet agents, and may be a method of preventing progressive occlusion of palliative shunts. Blackwell Publishing Ltd 2014-02-28 /pmc/articles/PMC3959668/ /pubmed/24518555 http://dx.doi.org/10.1161/JAHA.113.000689 Text en © 2014 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Kutty, Shelby
Wu, Juefei
Hammel, James M.
Abraham, Joseph R.
Venkataraman, Jeeva
Abdullah, Ibrahim
Danford, David A.
Radio, Stanley J.
Lof, John
Porter, Thomas R.
Prevention of Arteriovenous Shunt Occlusion Using Microbubble and Ultrasound Mediated Thromboprophylaxis
title Prevention of Arteriovenous Shunt Occlusion Using Microbubble and Ultrasound Mediated Thromboprophylaxis
title_full Prevention of Arteriovenous Shunt Occlusion Using Microbubble and Ultrasound Mediated Thromboprophylaxis
title_fullStr Prevention of Arteriovenous Shunt Occlusion Using Microbubble and Ultrasound Mediated Thromboprophylaxis
title_full_unstemmed Prevention of Arteriovenous Shunt Occlusion Using Microbubble and Ultrasound Mediated Thromboprophylaxis
title_short Prevention of Arteriovenous Shunt Occlusion Using Microbubble and Ultrasound Mediated Thromboprophylaxis
title_sort prevention of arteriovenous shunt occlusion using microbubble and ultrasound mediated thromboprophylaxis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959668/
https://www.ncbi.nlm.nih.gov/pubmed/24518555
http://dx.doi.org/10.1161/JAHA.113.000689
work_keys_str_mv AT kuttyshelby preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis
AT wujuefei preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis
AT hammeljamesm preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis
AT abrahamjosephr preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis
AT venkataramanjeeva preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis
AT abdullahibrahim preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis
AT danforddavida preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis
AT radiostanleyj preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis
AT lofjohn preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis
AT porterthomasr preventionofarteriovenousshuntocclusionusingmicrobubbleandultrasoundmediatedthromboprophylaxis